For paths that have
not yet been taken,
there lie two opposing attitudes:
Fear that the path
ahead is unknown,
and savor the excitement of pioneering a new path from the unknown
At GC Biopharma, our core mission revolves around one fundamental question: How can we accelerate the development of new drugs that patients have been eagerly anticipating? As trailblazers in the field of bio-pharmaceuticals, we take great pride in our ability to continuously develop groundbreaking plasma derivatives, vaccines, and recombinants. Through unwavering dedication to innovation, GC Biopharma has earned its place among the world's leading providers of life science solutions.
Making drugs that are
difficult to make,
Pioneering new groundbreaking
pathways forward
GC Biopharma has helped spearhead the development of drugs that are extremely difficult to make. We embrace the challenge as it frees patients from the despair of diseases. With our pioneering spirit, GC Biopharma continues to advance technology and develop specialized drugs that other pharmaceutical companies tend to avoid. We believe in the value of a society where everyone's quality of life is enhanced. We endeavor forward to achieve these goals globally.
Over the last 50 years
To the next 50 years
For the 100 years of humanity
Lies the path of a centennial enterprise
GC embodies its commitment and preparation for the next 50 years through a comprehensive mid- and long-term 2030 plan. This strategy represents five new global medicines, aiming to achieve 5 trillion won in sales and generate a corporate value of 50 trillion won. The goal is to establish ourselves as a leading company in the global health industry. Having already etched a new chapter in the history of the Korean pharmaceutical sector, GC now sets its sights on a transformative vision for the next half-century, driven by its profound mission and dedication to human health.